Unknown

Dataset Information

0

Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure.


ABSTRACT:

Background

HIV-1 infections occur following viral exposure at anogenital mucosal surfaces in the presence of semen. Semen contains immunosuppressive and pro-inflammatory factors. Semen from HIV-1-infected donors contains anti-HIV-1 antibodies. We assessed if passively infused anti-HIV-1 neutralizing antibody conferred protection from rectal SHIVSF162P3 challenge at semen exposed mucosae.

Methods

We pooled seminal plasma from HIV-1-infected donors. The pool was screened by ELISA for antibodies against HIV-1SF162 gp140. The ability of seminal plasma to inhibit macaque NK cells from responding to direct and antibody-dependent stimulation was assessed. The ability of seminal plasma to inhibit macaque granulocytes from mediating oxidative burst was also assessed. To demonstrate viral infectivity in the presence of seminal plasma, macaques (n = 4) were rectally challenged with SHIVSF162P3 following exposure to 2.5 mL of seminal plasma. To evaluate if anti-HIV-1 neutralizing antibody confers protection against rectal SHIV challenge at semen exposed mucosae, eight macaques were intravenously infused with PGT121, either wild type (n = 4) or the Fc receptor binding deficient LALA variant (n = 4), and rectally challenged with SHIVSF162P3 following exposure to 2.5 mL of seminal plasma.

Findings

Anti-HIV-1SF162 gp140 antibodies were detected in seminal plasma. Seminal plasma inhibited direct and antibody-dependent NK cell activation and granulocyte oxidative burst in vitro. Rectal SHIVSF162P3 challenge of control macaques following seminal plasma exposure resulted in infection of all animals. All macaques infused with wild type or LALA PGT121 and challenged with SHIVSF162P3 following seminal plasma exposure were protected.

Interpretation

PGT121 conferred protection against rectal SHIVSF162P3 challenge at semen exposed mucosae. Future research should investigate if semen alters protection conferred by antibodies more dependent on non-neutralizing functions.

SUBMITTER: Parsons MS 

PROVIDER: S-EPMC8361295 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC11006161 | biostudies-literature
| S-EPMC8636046 | biostudies-literature
| S-EPMC4570538 | biostudies-literature
| S-EPMC7187567 | biostudies-literature
| S-EPMC3642082 | biostudies-literature
| S-EPMC7876468 | biostudies-literature
| S-EPMC6307963 | biostudies-literature
| S-EPMC4437463 | biostudies-literature
| S-EPMC4125441 | biostudies-literature
| S-EPMC11257540 | biostudies-literature